The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Management of primary biliary cirrhosis
Abstract
Primary biliary cirrhosis (PBC) is a presumed autoimmune disease of the liver, which predominantly affects women once over the age of 20 years. Most cases are diagnosed when asymptomatic (60%). The antimitochondrial antibody is present in serum in most, but not in all, patients with PBC. The disease generally progresses slowly but survival is less than an age- and gender-matched general population. The symptomatic patient may have fatigue, generalized pruritus, portal hypertension, osteoporosis, skin xanthomata, fat soluble vitamin deficiencies, and/or recurrent asymptomatic urinary tract infections. Many nonhepatic autoimmune diseases are found in association with PBC and may prompt initial presentation. To date, immunosuppressive therapy has not been shown to prolong survival in PBC. The hydrophilic bile acid, ursodeoxycholic acid (UDCA), has been shown when given in a dose of 13 to 15 mg/kg daily for up to 4 years to delay the time to liver transplantation or death. This therapy also causes a significant improvement of all the biochemical markers of cholestasis but has no beneficial effects on any of the symptoms or associated disorders. Treatment with UDCA does not obviate the need for liver transplantation. Therapies to prevent complications arising from malabsorption, portal hypertension, and/or osteoporosis are required as well. Good control of pruritus can be achieved in most patients. PBC is diagnosed with increasing frequency, but the agent(s) responsible for this slowly progressive destruction of the interlobular bile ducts remains elusive and hence a specific therapy remains unavailable.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prognosis in primary biliary cirrhosis: Model for decision making
Dickson, R. E., Grambsch, P. M., Fleming, T. R., Fisher, L. D., & Langworthy, A. (1989) · Hepatology · doi:10.1002/hep.1840100102 · Cited by 816
Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)
Ludwig, J., Dickson, E. R., & McDonald, G. S. A. (1978) · Virchows Archiv A Pathological Anatomy and Histology · doi:10.1007/bf00432479 · Cited by 753
Poupon, R., Lindor, K., Cauch-Dudek, K., Dickson, E., Poupon, R., & Heathcote, E. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70183-5 · Cited by 648
Effect of Calcium Supplementation on Bone Loss in Postmenopausal Women
Reid, I. R., Ames, R. W., Evans, M. C., Gamble, G. D., & Sharpe, S. J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199302183280702 · Cited by 512
The presentation and diagnosis of 100 patients with primary biliary cirrhosis
Sherlock, S., & Scheuer, P. J. (1973) · New England Journal of Medicine · doi:10.1056/nejm197309272891306 · Cited by 504
Ursodiol for the Long-Term Treatment of Primary Biliary Cirrhosis
Poupon, R. E., Poupon, R., & Balkau, B. (1994) · New England Journal of Medicine · doi:10.1056/nejm199405123301903 · Cited by 497
Ursodeoxycholic acid in the treatment of primary biliary cirrhosis
Lindor, K. D., Dickson, E. R., Baldus, W. P., Jorgensen, R. A., Ludwig, J., Murtaugh, P. A., Harrison, J. M., Wiesner, R. H., Anderson, M. L., Lange, S. M., et al. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90021-3 · Cited by 487
Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis
Christensen, E., Neuberger, J., Crowe, J., Altman, D. G., Popper, H., Portmann, B., Doniach, D., Ranek, L., Tygstrup, N., & Williams, R. (1985) · Gastroenterology · doi:10.1016/0016-5085(85)90213-6 · Cited by 423
Natural history of early primary biliary cirrhosis
Metcalf, J. V., Mitchison, H. C., Palmer, J. M., Jones, D. E., Bassendine, M. F., & James, O. F. (1996) · The Lancet · doi:10.1016/s0140-6736(96)04410-8 · Cited by 421
Roll, J., Boyer, J. L., Barry, D., & Klatskin, G. (1983) · New England Journal of Medicine · doi:10.1056/nejm198301063080101 · Cited by 417
Bergasa, N. V., Alling, D. W., Talbot, T. L., Swain, M. G., Yurdaydin, C., Turner, M. L., Schmitt, J. M., Walker, E. C., & Jones, E. A. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-3-199508010-00001 · Cited by 365
Oral naltrexone treatment for cholestatic pruritus: A double-blind, placebo-controlled study
Wolfhagen, F., Sternieri, E., Hop, W., Vitale, G., Bertolotti, M., & Van Buuren, H. (1997) · Gastroenterology · doi:10.1053/gast.1997.v113.pm9322521 · Cited by 343
Primary sclerosing cholangitis: findings on cholangiography and pancreatography.
MacCarty, R. L., LaRusso, N. F., Wiesner, R. H., & Ludwig, J. (1983) · Radiology · doi:10.1148/radiology.149.1.6412283 · Cited by 333
Serum bilirubin: a prognostic factor in primary biliary cirrhosis
Shapiro, J. M., Smith, H., & Schaffner, F. (1979) · Gut · doi:10.1136/gut.20.2.137 · Cited by 319
Opioid peptides and primary biliary cirrhosis
Thornton, J. R., & Losowsky, M. S. (1988) · BMJ · doi:10.1136/bmj.297.6662.1501 · Cited by 300
Eastell, R., Dickson, R. E., Hodgson, S. F., Wiesner, R. H., Porayko, M. K., Wahner, H. W., Cedel, S. L., Riggs, L. B., & Krom, R. A. F. (1991) · Hepatology · doi:10.1002/hep.1840140215 · Cited by 297
Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis.
Fussey, S. P., Guest, J. R., James, O. F., Bassendine, M. F., & Yeaman, S. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.22.8654 · Cited by 273
COMBES, B. (1995) · Hepatology · doi:10.1016/0270-9139(95)90294-5 · Cited by 268
Treatment of pruritus of primary biliary cirrhosis with rifampin
Podesta, A., Lopez, P., Terg, R., Villamil, F., Flores, D., Mastai, R., Udaondo, C. B., & Companc, J. P. (1991) · Digestive Diseases and Sciences · doi:10.1007/bf01300759 · Cited by 267
Impact of fatigue on the quality of life of patients with primary biliary cirrhosis
Huet, P.-M., Deslauriers, J., Tran, A., Faucher, C., & Charbonneau, J. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.01857.x · Cited by 262
Treatment of pruritus in primary biliary cirrhosis with rifampin
Ghent, C. N., & Carruthers, S. G. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90442-8 · Cited by 257
Fatigue in primary biliary cirrhosis
Cauch-Dudek, K., Abbey, S., Stewart, D. E., & Heathcote, E. J. (1998) · Gut · doi:10.1136/gut.43.5.705 · Cited by 237
Michieletti, P., Wanless, I. R., Katz, A., Scheuer, P. J., Yeaman, S. J., Bassendine, M. F., Palmer, J. M., & Heathcote, E. J. (1994) · Gut · doi:10.1136/gut.35.2.260 · Cited by 236
Effects of long-term rifampicin administration in primary biliary cirrhosis
Bachs, L., Parés, A., Elena, M., Piera, C., & Rodés, J. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90335-v · Cited by 235
Efficacy of Liver Transplantation in Patients with Primary Biliary Cirrhosis
Markus, B. H., Dickson, E. R., Grambsch, P. M., Fleming, T. R., Mazzaferro, V., Klintmalm, G. B. G., Wiesner, R. H., Van Thiel, D. H., & Starzl, T. E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906293202602 · Cited by 234
Mitchison, H. C., Bassendine, M. F., Hendrick, A., Bennett, M. K., Bird, G., Watson, A. J., & James, O. F. W. (1986) · Hepatology · doi:10.1002/hep.1840060609 · Cited by 230
Autoimmune Associations in Primary Biliary Cirrhosis
Culp, K. S., Fleming, C. R., Duffy, J., Baldus, W. P., & Dickson, E. R. (1982) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(25)18890-3 · Cited by 229
Bone Loss and Reduced Osteoblast Function in Primary Biliary Cirrhosis
HODGSON, S. F., DICKSON, E. R., WAHNER, H. W., JOHNSON, K. A., MANN, K. G., & RIGGS, B. L. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-103-6-855 · Cited by 228
Primary biliary cirrhosis with scleroderma, Raynaud's phenomenon and telangiectasia
Reynolds, T. B., Denison, E. K., Frankl, H. D., Lieberman, F. L., & Peters, R. L. (1971) · The American Journal of Medicine · doi:10.1016/0002-9343(71)90218-x · Cited by 225
Purpose of Quality Standards for Infectious Diseases
Gross, P. A., Barrett, T. L., Dellinger, E. P., Krause, P. J., Martone, W. J., McGowan, J. E., Sweet, R. L., & Wenzel, R. P. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.3.421 · Cited by 223
Multisystem involvement in chronic liver disease
Golding, P. L., Smith, M., & Williams, R. (1973) · The American Journal of Medicine · doi:10.1016/0002-9343(73)90258-1 · Cited by 218
Autoimmune cholangiopathy: Part of the spectrum of autoimmune chronic active hepatitis
Ben-Ari, Z., Dhillon, A. P., & Sherlock, S. (1993) · Hepatology · doi:10.1002/hep.1840180103 · Cited by 218
Bacteriuria and primary biliary cirrhosis.
Burroughs, A. K., Rosenstein, I. J., Epstein, O., Hamilton-Miller, J. M., Brumfitt, W., & Sherlock, S. (1984) · Gut · doi:10.1136/gut.25.2.133 · Cited by 214
The Pancreas in Primary Biliary Cirrhosis and Primary Sclerosing Cholanitis
Epstein, O., Chapman, R. W. G., Lake-Bakaar, G., Foo, A. Y., Rosalki, S. B., & Sherlock, S. (1982) · Gastroenterology · doi:10.1016/s0016-5085(82)80125-x · Cited by 211
Kingham, J. G. C., & Parker, D. R. (1998) · Gut · doi:10.1136/gut.42.1.120 · Cited by 207
Primary biliary cirrhosis: Paradigm or paradox for autoimmunity
Gershwin, M. E., & Mackay, I. R. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)80033-6 · Cited by 206
Molecular aspects of membrane stabilization by ursodeoxycholate
Güldütuna, S., Zimmer, G., Imhof, M., Bhatti, S., You, T., & Leuschner, U. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90653-t · Cited by 206
A controlled trial of prednisolone treatment in primary biliary cirrhosis
Mitchison, H. C., Palmer, J. M., Bassendine, M. F., Watson, A. J., Record, C. O., & James, O. F. W. (1992) · Journal of Hepatology · doi:10.1016/0168-8278(92)90065-w · Cited by 199
Antimitochondrial antibody-negative primary biliary cirrhosis.
Lacerda, M. A., Ludwig, J., Dickson, E. R., Jorgensen, R. A., & Lindor, K. (1995) · PubMed · Cited by 185
Bile acid concentrations in human and rat liver tissue and in hepatocyte nuclei
Setchell, K., Rodrigues, C., Clerici, C., Solinas, A., Morelli, A., Gartung, C., & Boyer, J. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70239-7 · Cited by 185
The Demography of Primary Biliary Cirrhosis in Ontario, Canada
Witt-Sullivan, H., Heathcote, J., Cauch, K., Blendis, L., Ghent, C., Katz, A., Milner, R., Pappas, C. S., Rankin, J., & Wanless, I. R. (1990) · Hepatology · doi:10.1002/hep.1840120116 · Cited by 181
Self-citationGoodman, Z. D., McNally, P. R., Davis, D. R., & Ishak, K. G. (1995) · Digestive Diseases and Sciences · doi:10.1007/bf02065530 · Cited by 178
Ursodeoxycholic acid delays the onset of esophageal varices in primary biliary cirrhosis
Lindor, K. D., Jorgensen, R. A., Therneau, T. M., Malinchoc, M., & Dickson, E. R. (1997) · Mayo Clinic Proceedings · doi:10.4065/72.12.1137 · Cited by 166
Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes
Jones, D. E., Metcalf, J. V., Collier, J. D., Bassendine, M. F., & James, O. F. (1997) · Hepatology · doi:10.1002/hep.510260508 · Cited by 161
Lombard, M. G., Portmann, B., Neuberger, J., Williams, R. L., Tygstrup, N., Ranek, L., Ring‐Larsen, H., Rodés, J., Navasa, M., TREPO, C. G., et al. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90422-9 · Cited by 153
Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis
Czaja, A. J., Carpenter, H. A., & Manns, M. P. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90160-e · Cited by 150
Hypercholesterolemia and Atherosclerosis in Primary Biliary Cirrhosis: What Is the Risk?
Crippin, J. S., Lindor, K. D., Jorgensen, R., Kottke, B. A., Harrison, J. M., Murtaugh, P. A., & Dickson, R. E. (1992) · Hepatology · doi:10.1002/hep.1840150518 · Cited by 149
Crowe, S. F., Christensen, E., Butler, J., Wheeler, P. G., Doniach, D., Keenan, J. P., & Williams, R. L. (1980) · Gastroenterology · doi:10.1016/s0016-5085(19)30497-4 · Cited by 148
Springer, J., Cole, D. E. C., Rubin, L. A., Cauch‐Dudek, K., Harewood, L., Evrovski, J., Peltekova, V. D., & Heathcote, E. J. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70423-9 · Cited by 147
Asymptomatic primary biliary cirrhosis: a study of its natural history and prognosis
Springer, J., Cauch-Dudek, K., O'Rourke, K., Wanless, I. R., & Heathcote, E. J. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.00770.x · Cited by 141
Diminished survival in asymptomatic primary biliary cirrhosis
Balasubramaniam, K., Grambsch, P. M., Wiesner, R. H., Lindor, K. D., & Dickson, E. R. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)91091-j · Cited by 141
Kinetics of hepatic bile acid handling in cholestatic liver disease: Effect of ursodeoxycholic acid
Jazrawi, R. P., Caestecker, J. S. D., Goggin, P. M., Britten, A. J., Joseph, A. E. A., Maxwell, J. D., & Northfield, T. C. (1994) · Gastroenterology · doi:10.1016/s0016-5085(94)94899-2 · Cited by 129
Hepatic osteodystrophy in primary biliary cirrhosis: effects of medical treatment.
Crippin, J. S., Ra, J., Dickson, E. R., & Kd, L. (1994) · PubMed · Cited by 128
Bone disease in primary biliary cirrhosis: Does ursodeoxycholic acid make a difference?
Lindor, K. D., Janes, C. H., Crippin, J. S., Jorgensen, R. A., & Dickson, R. E. (1995) · Hepatology · doi:10.1002/hep.1840210219 · Cited by 124
Naumann, M., Савицкая, Н. Г., Eilert-Micus, C., Schramm, A. R., Kalthoff, H., & Schmiegel, W. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8613012 · Cited by 122
Is mitochondrial antibody diagnostic of primary biliary cirrhosis?
Muñoz-Espinosa, L. E., Thomas, H. C., Scheuer, P. J., Doniach, D., & Sherlock, S. (1981) · Gut · doi:10.1136/gut.22.2.136 · Cited by 119
Wolfhagen, F. H. J., van Buuren, H. R., den Ouden, J. W., Hop, W. C. J., van Leeuwen, J. P. T. M., Schalm, S. W., & Pols, H. A. P. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80048-7 · Cited by 116
Treatment of Pruritus of Obstructive Jaundice with Cholestyramine
Datta, D. V. (1963) · BMJ · doi:10.1136/bmj.1.5325.216 · Cited by 116
Colina, F., Pinedo, F., Solis, J. A., Moreno, D. B., & Nevado, M. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90771-p · Cited by 116
Taylor, S. L., Dean, P. J., & Riely, C. A. (1994) · PubMed · Cited by 114
Vuoristo, M., Färkkilä, M. A., Karvonen, A., Leino, R., Lehtola, J., Mäkinen, J., Mattila, J. J., Friman, C., Seppälä, K., Tuominen, J., et al. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90696-7 · Cited by 113
Evidence for disease recurrence after liver transplantation for primary biliary cirrhosis
Polson, R. J., Portmann, B., Neuberger, J., Calne, R., & Williams, R. L. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90643-4 · Cited by 111
Brunner, G. H. G., & Klinge, O. (2008) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-2008-1068269 · Cited by 109
Treatment of primary biliary cirrhosis with low-dose weekly methotrexate
Kaplan, M. M., & Knox, T. A. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90085-y · Cited by 105
Ricci, P., Therneau, T. M., Malinchoc, M., Benson, J. T., Petz, J., Klintmalm, G. B. G., Crippin, J. S., Wiesner, R. H., Steers, J. L., Rakela, J. L., et al. (1997) · Hepatology · doi:10.1002/hep.510250330 · Cited by 104
Histological evidence for recurrence of primary biliary cirrhosis after liver transplantation
Balan, V., Batts, K. P., Porayko, M. K., Krom, R. A. F., Ludwig, J., & Wiesner, R. H. (1993) · Hepatology · doi:10.1002/hep.1840180617 · Cited by 102
Hendrickse, M. T., Rigney, E., Giaffer, M. H., Soomro, I. N., Triger, D. R., Underwood, J. C. E., & Gleeson, D. C. (1999) · Gastroenterology · doi:10.1053/gast.1999.0029900400 · Cited by 101
Incidence of cancer in primary biliary cirrhosis: the Mayo experience
Nijhawan, P. K., Therneau, T. M., Dickson, R. E., Boynton, J., & Lindor, K. D. (1999) · Hepatology · doi:10.1002/hep.510290511 · Cited by 99
Prediction of prognosis of primary biliary cirrhosis in Japan
Inoue, K., Hirohara, J., Nakano, T., Seki, T., Sasaki, H., Higuchi, K., Ohta, Y., Onji, M., Muto, Y., & Moriwaki, H. (1995) · Liver International · doi:10.1111/j.1600-0676.1995.tb00110.x · Cited by 98
Immunosuppressive properties of chenodeoxycholic and ursodeoxycholic acids in the mouse
Calmus, Y., Weill, B. J., Ozier, Y. M., Chéreau, C., Houssin, D. P., & Poupon, R. Y. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90855-s · Cited by 97
Lindor, K. D., Dickson, R. E., Jorgensen, R. A., Anderson, M. L., Wiesner, R. H., Gores, G. J., Lange, S. M., Rossi, S. S., Hofmann, A. F., & Baldus, W. P. (1995) · Hepatology · doi:10.1016/0270-9139(95)90624-x · Cited by 95
Taylor, S. L., Dean, P. J., & Riely, C. A. (1994) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199401000-00009 · Cited by 95
Kilmurry, M. R., Heathcote, E. J., Cauch-Dudek, K., O’Rourke, K., Bailey, R. J., Blendis, L. M., Ghent, C. N., Minuk, G. Y., Pappas, S. C., Scully, L. J., et al. (1996) · Hepatology · doi:10.1002/hep.510230532 · Cited by 94
Malignancy in primary biliary cirrhosis
Wolke, A. M., Schaffner, F., Kapelman, B., & Sacks, H. S. (1984) · The American Journal of Medicine · doi:10.1016/0002-9343(84)90861-1 · Cited by 93
Prevalence and pattern of familial disease in primary biliary cirrhosis.
Brind, A. M., Bray, G. P., Portmann, B. C., & Williams, R. L. (1995) · Gut · doi:10.1136/gut.36.4.615 · Cited by 91
Cancer Risk in Primary Biliary Cirrhosis: A Population–Based Study From Sweden
Lööf, L., Adami, H., Sparén, P., Danielsson, Å., Eriksson, L. S., Hultcrantz, R. W., Lindgren, S. C., Olsson, R., Prytz, H., Rydén, B.-O., et al. (1994) · Hepatology · doi:10.1002/hep.1840200116 · Cited by 86
Parenteral Calcitonin for Metabolic Bone Disease Associated With Primary Biliary Cirrhosis
Crosignani, A. L., Battezzati, P. M., Albisetti, W., Grandinetti, G., Pietrogrande, L., Biffi, A., Zuin, M. G., & Podda, M. (1994) · Hepatology · doi:10.1002/hep.1840200313 · Cited by 80
Characterisation of patients with a complete biochemical response to ursodeoxycholic acid.
Jorgensen, R. A., Dickson, E. R., Hofmann, A. F., Rossi, S. S., & Lindor, K. D. (1995) · Gut · doi:10.1136/gut.36.6.935 · Cited by 77
Cholesterol-lowering effect of ursodeoxycholic acid in patients with primary biliary cirrhosis
Poupon, R. E., Ouguerram, K., Chrétien, Y., Verneau, C., Eschwège, É., Magot, T., & Poupon, R. Y. (1993) · Hepatology · doi:10.1002/hep.1840170408 · Cited by 72
Breast cancer in women with primary biliary cirrhosis.
Goudie, B. M., Burt, A. D., Boyle, P., Macfarlane, G. J., Birnie, G. G., Mills, P. R., Gillis, C. R., MacSween, R. N. M., & Watkinson, G. (1985) · BMJ · doi:10.1136/bmj.291.6509.1597 · Cited by 71
Jeffrey, G. P., Muller, D. P. R., Burroughs, A. K., Matthews, S., Kemp, C. M., Epstein, O., Metcalfe, T., Southam, E., Tazir, M., Thomas, P. K., et al. (1987) · Journal of Hepatology · doi:10.1016/s0168-8278(87)80539-1 · Cited by 70
An autoantibody profile in primary sclerosing cholangitis
Zauli, D., Schrumpf, E., Crespi, C., Cassani, F., FAUSA, O., & Aadland, E. (1987) · Journal of Hepatology · doi:10.1016/s0168-8278(87)80055-7 · Cited by 69
Sodium fluoride prevents bone loss in primary biliary cirrhosis
Guañabens, N., Parés, A., del Rio, L., Roca, M., Gómez, R., Muñoz, J., & Rodés, J. (1992) · Journal of Hepatology · doi:10.1016/0168-8278(92)90066-x · Cited by 68
Parenteral calcitonin for metabolic bone disease associated with primary biliary cirrhosis
Camisasca, M. (1994) · Hepatology · doi:10.1016/0270-9139(94)90098-1 · Cited by 66
Pathogenesis of Steatorrhea in Primary Biliary Cirrhosis
Lanspa, S. J., Chan, A., Bell, S. J., Go, V. L. W., Dickson, R. E., & DiMagno, E. P. (1985) · Hepatology · doi:10.1002/hep.1840050522 · Cited by 63
Pruritus of cholestasis is related to effects of bile salts on the liver, not the skin.
Ghent, C. N. (1987) · PubMed · Cited by 59
Primary biliary cirrhosis, sicca complex, and dysphagia
Mang, F.-W., Michieletti, P., O'Rourke, K., Cauch-Dudek, K., Diamant, N., Bookman, A., & Heathcote, J. (1997) · Dysphagia · doi:10.1007/pl00009532 · Cited by 57
Self-citationMuñoz, S. J., Heubi, J. E., Balistreri, W. F., & Maddrey, W. C. (1989) · Hepatology · doi:10.1002/hep.1840090403 · Cited by 55
Immunological Study of Anti-M2 in Antimitochondrial Antibody-Negative Primary Biliary Cirrhosis.
KITAMI, N., KOMADA, T., ISHII, H., Shimizu, H., Adachi, H., Yamaguchi, Y., Kitamura, T., Oide, H., Miyazaki, A., Ishikawa, M., et al. (1995) · Internal Medicine · doi:10.2169/internalmedicine.34.496 · Cited by 46
Combined treatment with ursodeoxycholic acid and prednisone in primary biliary cirrhosis.
Wolfhagen, F., van Buuren, H. R., & Schalm, S. W. (1994) · PubMed · Cited by 45
van de Meeberg, P. C., Wolfhagen, F. H. J., Henegouwen, G. P. V. B., Salemans, J. M. J. I., Tangerman, A., van Buuren, H. R., van Hattum, J., & van Erpecum, K. J. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80293-5 · Cited by 45
Caldwell, S. H., Leung, P. S. C., Spivey, J. R., Prindiville, T. P., de Medina, M. D., Saicheur, T., Rowley, M. J., Reddy, K. R., Coppel, R. L., Jeffers, L. J., et al. (1992) · Hepatology · doi:10.1002/hep.1840160408 · Cited by 35
Primary biliary cirrhosis and ulcerative colitis
Bush, A., Mitchison, H., Walt, R. P., Baron, J. H., Boylston, A. W., & Summerfield, J. A. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)90636-6 · Cited by 33
Arthritis of Primary Biliary Cirrhosis
Marx, W. J. (1979) · Archives of Internal Medicine · doi:10.1001/archinte.1979.03630390065024 · Cited by 29
Heathcote, E. J., Stone, J., Cauch‐Dudek, K., Poupon, R. Y., Chazouillères, O., Lindor, K. D., Petz, J., Dickson, E. R., & Poupon, R. E. (1999) · Liver Transplantation and Surgery · doi:10.1002/lt.500050419 · Cited by 27
Pregnancy in patients with primary biliary cirrhosis — a case for dissuasion?
Olsson, R., Lööf, L., Wallerstedt, S., & Club, T. S. I. M. L. (1993) · Liver International · doi:10.1111/j.1600-0676.1993.tb00652.x · Cited by 26
Timing of Cholestyramine Doses in Cholestatic Liver Disease
(1974) · New England Journal of Medicine · doi:10.1056/nejm197406062902326 · Cited by 23
Effect of distal splenorenal shunt on survival of patients with primary biliary cirrhosis
Boyer, T. D., Kokenes, D. D., Hertzler, G., Kutner, M. H., & Henderson, M. J. (1994) · Hepatology · doi:10.1002/hep.1840200617 · Cited by 20
Portal hypertension in patients with primary biliary cirrhosis
Huet, P., Ruiz-Matas, J. H., & Deslauriers, J. (1998) · Springer eBooks · doi:10.1007/978-94-011-4884-9_10 · Cited by 9
A Follow‐up Study of 68 Patients with Anti‐mitochondrial Antibodies (AMA)
Jorde, R., Rekvig, O. P., & Bostad, L. H. (1986) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1986.tb02758.x · Cited by 8
Heathcote, J. E., Cauch-Dudek, K., Walker, V., Bailey, R. J., Blendis, L. M., Ghent, C. N., Michieletti, P., Minuk, G. Y., Pappas, C. S., Scully, L. J., et al. (1994) · Hepatology · doi:10.1002/hep.1840190512 · Cited by 2
Self-citation
Cited by
Rockey, D. C., Caldwell, S. H., Goodman, Z. D., Nelson, R. C., & Smith, A. D. (2009) · Hepatology · doi:10.1002/hep.22742 · Cited by 1,997
EASL Clinical Practice Guidelines: management of cholestatic liver diseases
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.04.009 · Cited by 1,729
AASLD practice guidelines: Evaluation of the patient for liver transplantation†
Murray, K. F., & Carithers, R. L. (2005) · Hepatology · doi:10.1002/hep.20704 · Cited by 939
Primary Biliary Cirrhosis Associated with HLA, IL12A, and IL12RB2 Variants
Hirschfield, G. M., Liu, X., Xu, C., Lu, Y., Xie, G., Lu, Y., Gu, X., Walker, E. J., Jing, K., Juran, B. D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810440 · Cited by 594
Boberg, K. M., Chapman, R. W., Hirschfield, G. M., Lohse, A. W., Manns, M. P., & Schrumpf, E. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.09.002 · Cited by 555
Metadata
- Authors
- Heathcote, J. E.
- Venue
- Hepatology
- Published
- 2000-04
- Volume
- 31
- Issue
- 4
- Pages
- 1005-1013
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1991166786
- Cited by
- 417
- References
- 102
- FWCI
- 14.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.